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Transgenic mice were generated expressing an a1 connexin/b-galactosidase fusion protein previously shown to exert
dominant negative effects on gap junctional communication. RNase protection analysis and assays for b-galactosidase
enzymatic activity showed that the transgene RNA and protein are expressed in the embryo and adult tissues. In situ
hybridization analysis revealed that in the embryo, expression was predominantly restricted to neural crest cells and their
progenitors in the dorsal neural tube, regions where the endogenous a1 connexin gene is also expressed. Dye-coupling
analysis indicated that gap junctional communication was inhibited in the cardiac neural crest cells. All of the transgenic
lines were homozygote inviable, dying neonatally and exhibiting heart malformations involving the right ventricular
outflow tract—the same region affected in the a1 connexin knockout mice. As in the knockout mice, the conotruncal heart
malformations were accompanied by outflow tract obstruction. Histological analysis showed that this was associated with
abnormalities in the differentiation of the conotruncal myocardium. These results suggest that the precise level of gap
junctional communication in cardiac neural crest cells is of critical importance in right ventricular outflow tract
morphogenesis. Consistent with this possibility is the fact that cardiac crest cells from the a1 connexin knockout mice also
exhibited a greatly reduced level of gap junctional communication. These studies show the efficacy of a dominant negative
approach for manipulating gap junctional communication in the mouse embryo and demonstrate that targeted expression
of this fusion protein can be a powerful tool for examining the role of gap junctions in mammalian
development. © 1998 Academic Press
Key Words: gap junctions; heart defect; neural crest; outflow tract; conotruncus; a1 connexin; connexin 43; gap junctional
communication; Doppler echocardiography.
INTRODUCTION
Gap junctions are membrane channels that mediate the
transfer of ions and small molecules between cells (Beyer et
al., 1990; Bennett et al., 1991; Kumar and Gilula, 1992;
Bruzzone et al., 1996). They have been proposed to mediate
cell–cell signaling involved in the regulation of growth and
development (Loewenstein and Rose, 1992; Warner, 1992; Lo,
1996). Gap junctions are composed of polypeptides encoded by
the connexin multigene family. Recent studies suggest that
the a1 connexin gene (also referred to as Cx43) plays an
important role in cardiac morphogenesis. One indication of
this is the finding of right ventricular outflow tract (RVOFT)
obstructions in the a1 connexin knockout mice (Reaume et
al., 1995). This cardiac phenotype yielded little insight into
the role of gap junctions in cardiac morphogenesis, as there is
little a1 connexin detected in the outflow tract (Van Kempen
et al., 1991; Gourdie et al., 1992; Moorman and Lamers, 1995).
However, as development of the outflow tract is known to be
dependent on the activity of neural crest cells (Kirby, 1993;
Waldo and Kirby, 1995), one possibility is that the RVOFT
heart malformations may arise from the perturbation of crest
cells.
Neural crest cells are observed to migrate not as indi-
vidual cells, but rather in groups organized in streams or
sheets (Bancroft and Bellairs, 1976; Davis and Trinkaus,1 To whom correspondence should be addressed.
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1981). Several studies have indicated an important role for
cell–cell interactions in modulating crest activity in devel-
opment (Rovasio et al., 1983; Raible and Eisen, 1996). Of
particular significance is the fact that migrating crest cells
express a1 connexins (Ruangvoravat and Lo, 1992; Lo et al.,
1997). They have also been shown to be functionally
coupled via gap junctions (Lo et al., 1997). In a recent study,
transgenic mice were generated expressing an a1 connexin
transgene driven by the cytomegaloviral promoter. In such
mice (CMV43), transgene expression was restricted to sub-
populations of neural crest cells, including the cardiac crest
cells. Given that neural crest cells express the endogenous
a1 connexin gene, it is not surprising that this resulted in
an increase in gap junctional communication in the cardiac
neural crest cells. RVOFT heart defects were observed in
these mice, even though the CMV43 transgene was not
expressed in the myocardium (Ewart et al., 1997). These
observations suggest that the role of a1 connexins in
cardiac morphogenesis likely involves the modulation of
cardiac neural crest cells (Ewart et al., 1997). However, one
puzzling aspect of these findings is how both the gain and
loss of a1 connexin function can result in conotruncal heart
defects. This raises some doubt as to the role of crest cells
in heart defects in the a1 connexin KO mice.
To further elucidate the role of a1 connexins in cardiac
development, in this study we examined the develop-
mental effects of downregulating gap junctional commu-
nication in crest cells using a dominant negative ap-
proach. For these studies, transgenic mice were generated
expressing an a1 connexin/b-galactosidase fusion protein
construct driven by the human elongation factor-1a
promoter. Previous studies showed that this construct
can provide high-level fusion protein expression and
inhibit gap junctional communication in cells with an
abundance of endogenous a1 connexins (Sullivan and Lo,
1995). Surprisingly, very few viable transgenic animals
were obtained with this construct. Nevertheless, three
fertile founder lines were isolated, and all three were
found to be homozygous inviable. RNA and protein
analysis of these three lines showed that the fusion
protein was expressed, but at a low level. In the embryo,
expression was predominantly localized to the dorsal
neural tube and subpopulations of neural crest cells.
Dye-coupling analysis showed that gap junctional com-
munication in the cardiac crest cells was reduced. Sig-
nificantly, these transgenic mice exhibited heart malfor-
mations involving the RVOFT. Together with previous
studies (Reaume et al., 1995; Ewart et al., 1997), these
results indicate a central role for a1 connexins in right
ventricular outflow tract development. More impor-
tantly, they further indicate that the role of a1 connexins
in cardiac morphogenesis involves the modulation of
cardiac neural crest cells. These studies also show for the
first time that a dominant negative approach can be used
effectively to manipulate gap junctional communication
in the developing mouse embryo.
MATERIALS AND METHODS
Production and Genotyping of Transgenic Mice
To generate transgenic mice, the SalI/HindIII fragment of the
pEFZ plasmid (Sullivan and Lo, 1995) was injected into eggs
obtained from the breeding of B6/SJL F1 mice (NICHD Transgenic
Mouse Development Facility, DNX Inc., Princeton, NJ). Southern
blot analysis was used to analyze and confirm transgenic founder
animals identified by slot blot and PCR analysis. PCR analysis is
carried out using primers (59-TACCAACAGCGGATGGTTCGG-
39; 59-GTGGTGGTTTATGCCCGATCC-39) within the lacZ por-
tion of the fusion protein construct (according to Echelard et al.,
1994).
RNA Isolation and RNAase Protection Analysis
RNA was collected from adult tissues and whole embryos using
RNAzol B (Biotecx Laboratories, Inc., Houston, TX) according to
the manufacturer’s protocol. RNAase protection analysis was per-
formed with a RPA I kit from Ambion Inc. (Austin, TX), using a
32P-radiolabeled riboprobe to a portion of the lacZ coding sequence
(EcoRV/Cla fragment, nucleotides 619–1108 of bacterial
b-galactosidase). This probe gives a 489-nt protected fragment. In
addition, a 32P radiolabeled actin or 18S ribosomal riboprobe was
included as an internal control to normalize for RNA loading.
Briefly, RNA samples were hybridized with riboprobes overnight at
43°C (1 3 105 cpm). RNAase digestion was performed using
RNAaseA (0.45 u/ml) and RNAaseT1 (900 u/ml). Protected frag-
ments were subsequently loaded onto 8 M urea/6% acrylamide
sequencing gels with DNA sequencing ladders loaded in parallel for
size determination.
Quantitation of b-Galactosidase Enzyme Activity
b-Galactosidase activity was determined using the Galacto-
Light chemiluminescent assay system of Tropix (Bedford, MA). For
the analysis of enzyme activity in the embryo, individual E9.5 and
E10.5 embryos (plug date 5 E0.5) were extracted in the lysis buffer
provided by the manufacturer. For the analysis of adult testis or
heart, or fetal heart samples, tissues were homogenized in the same
lysis buffer using a Dounce homogenizer. For the quantitation of
b-galactosidase activity, the reaction mixture was initially incu-
bated for 60 min and then assayed for 10 s after injection of 200 ml
Galacton-accelerator to the sample using the Monolight luminom-
eter (Analytical Luminescence Laboratory). Each sample was as-
sayed in triplicate and the b-galactosidase activity was normalized
against the protein concentration.
Immunohistochemistry
For immunohistochemical analysis of transgene expression,
adult animals were perfused with 4% paraformaldehyde in
phosphate-buffered saline (PBS). Following perfusion, brain and
testes or ovary were dissected and further fixed in 4% paraformal-
dehyde in PBS at 4°C overnight and then cryoprotected with 30%
sucrose, frozen, and stored at 270°C until sectioning. Cryosections
were mounted on chromalum–gelatin-coated slides. Immunostain-
ing was performed using a b-galactosidase polyclonal antibody
(Cappel Laboratories, West Chester, PA), with detection carried out
with a fluorescein (FITC)-conjugated goat anti-rabbit IgG secondary
antibody (Cappel Laboratories). Some tissue sections were also
examined for b-galactosidase enzyme activity by histochemical
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staining with X-gal. For standard histology and immunodetection
of the marker a-smooth muscle actin, embryos were fixed in
Amsterdam’s fixative (Ewart et al., 1997), and after paraffin embed-
ding, and sectioning, the sections were examined using an indirect
conjugated method which allowed detection of monoclonal anti-
body binding to mouse tissues (Huang et al., 1998).
Section and Whole-Mount in Situ Hybridization
Analysis
Embryos for in situ hybridization analysis were fixed in modified
Carnoy’s fixative and embedded in paraffin (Ruangvoravat and Lo,
1992). Ten-micrometer sections were cut and mounted on slides
coated with 3-aminopropyltriethoxysilane. In situ hybridization
was carried out as previously described (Ruangvoravat and Lo,
1992) using sense or antisense 35S-radiolabeled riboprobes. After
hybridization, slides were coated with Kodak NTB2 emulsion,
exposed for 3 weeks, and developed. Slides were further stained
with 0.1% toluidine blue and mounted with Permount. Sections
were examined under phase-contrast and darkfield optics using a
Leitz Ortholux upright microscope and photographed using Kodak
T-Max 400 print film.
Whole-mount in situ hybridization of E9.5 and E10.5 embryos
was carried out with digoxigenin–UTP-labeled lacZ riboprobes. For
this analysis, embryos were fixed for 2 h in 4% paraformaldehyde
at 4°C. Following fixation, embryos were washed in PBS containing
0.1% Tween 20 and stored in 100% methanol at 220°C. Embryos
were bleached, dehydrated, treated with 20 mg/ml proteinase K for
5 min at room temperature, and postfixed. After further treatment
with 0.1% sodium borohydride, prehybridization was carried out
for 1 h followed by overnight hybridization. Embryos were then
washed, treated with RNAase, and incubated with alkaline
phosphatase-conjugated anti-digoxygenin antibody preabsorbed
with embryo powder. After washes to remove unbound antibody,
alkaline phosphatase activity was detected using nitroblue tetra-
zolium and 5-bromo-4-chloro-3-indolylphosphate.
Quantitative Dye-Coupling Analysis
Dye coupling was monitored with microelectrode impalements
into the dorsal hindbrain neuroepithelium of E8.5 embryos derived
from FC or Cx43 knockout males mated to CD-1 females. This was
carried out using a previously described method (Ewart et al., 1997).
Briefly, embryos were opened along the hindbrain neural fold and
immobilized in a thin bed of 0.8% agarose. During microelectrode
impalements, embryos were maintained on a heated microscope
stage in phosphate-buffered L15 medium containing 10% fetal
bovine serum. Carboxyfluorescein (2%) was iontophoretically
ejected for a 2-min interval using 2-nA hyperpolarizing current
pulses of 0.5 s duration at a frequency of one per second. The
number of dye-filled cells was recorded immediately upon the
termination of dye injection.
In Utero Doppler Echocardiography
Doppler analysis was carried out in pregnant females on E12.5 to
E14.5 using previously described methods (Gui et al., 1996). In
brief, the pregnant female was sedated with Avertin (1.25 mg/5 g,
i.p.). Echocardiography imaging and Doppler patterns were ob-
tained using the Interspec XL (Conshohocken, PA) instrument by
placing the ultrasonic transducer (7.5 MHz) over the abdomen and
coupling the ultrasonic energy with an acoustic gel. Imaging at this
frequency is adequate to locate the embryos and the beating heart
and to orient the direction of the sagittal plane of the embryos. To
obtain blood velocities, the sample volume (2–5 mm length) of the
pulsed Doppler was placed over the entire heart. The high-pass
filter was set at its lowest setting of 50 Hz. The same embryo was
evaluated from several angles of insonation to determine the
maximal blood velocities (Huhta et al., 1990). The inflow and
outflow waveforms were recorded on tapes using a Panasonic
AG6300 videocasette recorder (Tokyo, Japan) and analyzed using
an echocardiography analysis system (Digisonics, Inc., Houston,
TX).
RESULTS
Transgenic mice containing the a1 connexin/b-
galactosidase fusion protein construct were obtained at a
much lower frequency than expected (Table 1). Of 363
DNA-injected eggs transferred to foster mothers, only 7
transgenic founders were obtained (1.9%). This compares to
a 5–6% transgenic efficiency achieved with parallel injec-
tions of two lacZ reporter constructs expressing wild-type
b-galactosidase (Table 1). This result indicates that expres-
sion of the fusion protein is deleterious to the viability of
the transgenic animals. Consistent with this possibility is
the death of two transgenic founder animals prior to wean-
ing, one of which was recovered after death and found to be
hydrocephalic. Of the five viable founder animals, only
three were fertile (lines FA, FC, and FE, collectively referred
to as FZ). Mating of these three lines showed that they were
homozygous inviable, with presumptive homozygous ani-
mals dying neonatally. It is also likely that some hemizy-
gous transgenic animals are inviable, as 40% of the off-
spring from hemizygous X hemizygous crosses die before
weaning.
To determine if the a1 connexin/b-galactosidase trans-
gene was expressed in the three fertile FZ transgenic lines,
RNAase protection analysis was carried out using a lacZ
riboprobe. All three lines exhibited transgene expression in
E10.5 and E11.5 embryos, albeit expression levels were very
low (compared to tissue culture cell lines expressing the
same construct; see Sullivan and Lo, 1995) (Fig. 1). Line FC
and FE, but not line FA, also showed transgene expression
in adult tissues (Fig. 1 and data not shown). Expression was
detected only in the adult brain and gonads in line FC (see









pEFZ 363 26 (7.2%) 7a (1.9%)
pHXPLb 254 30 (11.8%) 13 (5.1%)
pHXPLDPb 171 29 (16.9%) 10 (5.8%)
a Two of these animals died, with one being hydrocephalic.
b pHXPL and pHXPLDP are lacZ reporter constructs.
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brain and testis, although transgene expression was also
observed in other adult tissues (Fig. 1).
To characterize the pattern of transgene expression dur-
ing embryogenesis, whole-mount and section in situ hy-
bridization analysis was carried out using E9.5 and E10.5
embryos (Fig. 2). These studies showed a surprisingly re-
stricted pattern of transgene expression. Hybridization sig-
nal was predominantly detected in the dorsal neuroepithe-
lium (see Figs. 2A and 2B, 2E and 2F, and 2G and 2H) and in
presumptive neural crest cells. Neural crest expression is
indicated by the presence of hybridization signal in cells
situated dorsolateral to the neural tube (see arrowheads in
Figs. 2E and 2G) and also in regions of the embryo known to
be populated by neural crest cells—such as in the frontona-
sal process (Figs. 2C and 2D), the branchial arches (Figs. 2C,
2D, 2K, and 2L), and the dorsal root ganglia (Figs. 2I and 2J).
In the heart, transgene expression was found in the outflow
tract, a structure known to contain neural crest cells (Fig.
2L). In addition, hybridization signal was found in some
regions of the pericardial sac (not shown) and at low levels
in the trabeculated myocardium (Figs. 2M and 2N). It
should be noted that much of the darkfield signal associated
with the heart in Fig. 2M is not hybridization signal, but
rather refraction of light due to red blood cells remaining
associated with the heart chamber. Aside from expression
in neural crest and crest-associated tissues, some transgene
expression was also found in the limb bud mesenchyme
(Figs. 2C and 2D) and the genital ridge (data not shown).
To examine for expression of the fusion protein, embryos
and adult tissues were harvested and assayed for
b-galactosidase enzymatic activity. Previous studies of tis-
sue culture cells expressing this fusion protein construct
had shown that the b-galactosidase moiety retained it
enzymatic activity (Sullivan and Lo, 1995). Low levels of
b-galactosidase activity were indeed detected in both the
adult and embryo tissues, a result consistent with the low
transcript levels seen by RNAase protection analysis (data
not shown). This was further confirmed by histochemical
staining with X-gal and immunohistochemical staining
with a b-galactosidase antibody (Fig. 3). Such studies
showed that in the adult testes, b-galactosidase protein and
enzymatic activity were associated with the Leydig cells
(Figs. 3A and 3C). In the brain, b-galactosidase protein can
be observed in subpopulations of neuronal cells. This was
seen by immunostaining (Fig. 3B), but not X-gal staining
(data not shown), a discrepancy likely due to the lower
fusion protein expression level associated with the brain
compared to the testes. In comparison, the b-galactosidase
antibody showed no specific immunostaining in brain sec-
tions from the nontransgenic littermates (Figs. 3D and 3E).
Quantitative Analysis of Gap Junctional
Communication
To determine if expression of the fusion protein had any
functional effects on gap junctional communication, dye-
injection studies were carried out to quantitate the level of
dye coupling in neural crest cells, a tissue in which fusion
protein expression was detected. Microelectrode impale-
ments were carried out into cells situated dorsolateral to
the postotic hindbrain neural folds of E8.5 embryos ob-
tained from nontransgenic females mated to hemizygous
FC males. This postotic hindbrain neural fold is a region
where both the transgene and the endogenous a1 connexin
gene are expressed and also the region from which cardiac
neural crest cells emerge (Kirby, 1993). The extent of dye
spread was monitored by counting the number of dye-filled
cells at the end of a 2-min impalement period. The genotype
of the embryos was subsequently determined by PCR
analysis of yolk sac DNA. These experiments revealed a
reduction in dye coupling in the FC transgenic embryos
compared to their nontransgenic littermates (Table 2; P ,
0.0001). These findings demonstrate that expression of the
fusion protein exerts a dominant negative effect on gap
FIG. 1. RNAase protection analysis of transgene RNA expression. RNAase protection was performed using a 32P-labeled lacZ riboprobe
(indicated as LacZ) with RNA from various tissues obtained from adult animals of lines FC and FE and from FE embryos. An 18S ribosomal
RNA probe was included to demonstrate RNA integrity (indicated as 18S). Note that a leak appeared in the well in which the FE testis
sample was loaded, thereby resulting in faint bands appearing on either side of this lane.
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junctional communication in the presumptive cardiac crest
cells. It is possible that this reduction in coupling is at least
in part due to the inhibition of gap junctional communica-
tion mediated by a1 connexins, as this connexin isotype is
expressed in neural crest cells (Lo et al., 1997). To examine
this question further, we examined dye coupling in cardiac
crest cells in the a1 connexin knockout mouse. Such
studies showed that in comparison to wild-type littermates,
there was a marked reduction in dye coupling in the
homozygous knockout embryos and an intermediate level
of dye coupling in the heterozygous knockout embryos
(Table 2). These results indicate a role for the endogenous
a1 connexin gene in mediating gap junctional communica-
tion in cardiac crest cells. The fact that a low level of dye
coupling persists in cardiac crest cells derived from the a1
connexin knockout mouse would suggest that other con-
nexins are likely expressed in this crest cell population.
Heart Malformation in the FZ Transgenic Mice
Given the homozygote lethality of the FZ transgenic
mice and the fact that heart defects are known to underlie
the a1 connexin knockout lethality, the FZ transgenic mice
were further examined for heart anomalies. These studies
showed that all three FZ transgenic lines have right ven-
tricular heart malformations (Figs. 4C and 4D). Typically
the right ventricle was enlarged, resulting in a deepening of
the interventricular cleft (see arrow in Figs. 4C and 4D).
FIG. 2. In situ hybridization analysis of transgene expression in transgenic embryos. Transgenic embryos (E9.5 and E10.5) were examined
by in situ hybridization analysis of histological sections using a 35S-labeled lacZ riboprobe (A–J, M, N) or by whole-mount in situ
hybridization using a digoxigenin-labeled lacZ riboprobe (K, L). (A–D) Sagittal sections of an E10.5 FA embryo demonstrate abundant
transgene expression in the dorsal neuroepithelium of the midbrain (m) and hindbrain (h) as well as expression in the branchial arches (a),
nasal placode (n), and limb (l). (E–H) Transverse sections through the spinal cord of an E9.5 FC embryo (E, F) and E10.5 FA embryo (G, H)
showed transgene expression in the dorsal neural tube (nt) and in cells dorsolateral to the neural tube (arrowheads), likely presumptive
neural crest cells. (I, J) Abundant transgene expression was also observed in the dorsal root ganglia (d). (K) An early E9.5 FC embryo exhibited
abundant transgene expression in the branchial arches (a), while a lower level was seen in the outflow tract (o). (L) A late E9.5 FA embryo
exhibited transgene expression in the branchial arches (a) and in the outflow tract (o). atria (at), ventricular (v), and outflow tract (o) regions
of the developing heart. (M, N) Analysis of an E9.5 FC transgenic embryo showed abundant transgene expression in the hindbrain (h)
neuroepithelium and in the atrial myocardium adjacent to the atrioventricular junction (open arrow). There also appears to be some
expression in the trabeculated ventricular myocardium (v). Scale bar, 200 mm.
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This was sometimes accompanied by visible distension of
the infundibulum (see open white arrow in Fig. 4D). Such
heart malformations were only found in offspring derived
from hemizygous 3 hemizygous crosses and never in hemi-
zygous 3 nontransgenic crosses, suggesting that the heart
defects are associated with homozygous animals. This was
confirmed in some cases by quantitative Southern blot
analysis of the transgene inserts. It should be noted that the
heart malformation is localized to the same region affected
in the a1 connexin knockout mice, but the phenotype is
FIG. 3. Cx43/b-galactosidase fusion protein expression in FC adult brain and testis. (A) In the testis, Leydig cells (ly) exhibited X-gal
staining. (B, C) In sections of the brain (B) and testis (C), immunostaining with an anti-b-galactosidase polyclonal antibody revealed fusion
protein expression in both tissues. In the testis, expression is localized to Leydig cells (ly), the same as that seen by X-gal staining (see A).
(D, E) Nontransgenic mouse brain immunostained in a parallel manner showed no staining with an anti-b-galactosidase antibody. Scale
bars, 100 mm. The image in B is at the same magnification as the image in C.
FIG. 4. Heart malformations in transgenic mice. (A). Neonatal heart from a nontransgenic littermate. This heart and all others shown here are
oriented with the right ventricle positioned to the left. (B) Neonatal heart from a homozygous a1 connexin knockout mouse. This heart shows
double outpouchings (open arrows) flanking the subpulmonary space of the outflow tract (p). (C, D) Hearts from neonatal mice obtained from FC
or FE heterozygous 3 heterozygous matings. Note dilation of the right ventricle (rv) and the resulting deepening of the interventricular cleft (solid
white arrow). In the FE heart (D), it is possible to observe outpouching or bulging of the conotruncal region encompassing the subpulmonary space
(see open arrow). P, pulmonary outflow tract. (E, F) Injection of trypan blue into the right ventricular (rv) chamber of the hearts from two
littermates derived from a FE 3 FE cross. In the nontransgenic heart (E), the injected dye readily exited from the pulmonary outflow tract (p).
However, in the transgenic heart (F), only a small amount exited from the pulmonary outflow tract (p), which is not visible in this photograph.
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distinct from that of the knockout mice. In the a1 connexin
knockout animal, typically the right ventricular outflow
tract defects are characterized by a double outpocketing at
the base of the outflow tract (Fig. 4B), a phenotype never
seen in the FZ transgenic mice.
Analysis of Cardiac Function
To determine if these heart malformations were accom-
panied by functional obstruction of the pulmonary outflow
tract as had been observed in the a1 connexin knockout
mice, we carried out trypan blue injection into the right
ventricular chamber of E17.5 fetal hearts. In contrast to
nontransgenic hearts, there is little dye movement out of
the pulmonary outflow tract of the hearts of presumptive
homozygous transgenic fetuses (Fig. 4F; compare to non-
transgenic heart in Fig. 4E). Outflow obstruction was fur-
ther indicated by in utero Doppler echocardiography of
E17.5 fetuses derived from hemizygous 3 hemizygous mat-
ings. Such studies showed a significant increase in the peak
systolic ejection velocity in 18% of the fetuses (Fig. 5; Table
3). A similar Doppler echo analysis of three litters derived
from the mating of hemizygous FC males with nontrans-
genic females showed ejection velocity indistinguishable
from that obtained with nontransgenic mice. The latter
result suggests that cardiac dysfunction is exhibited only by
the homozygous transgenic offspring. Given the expecta-
tion that 25% of the offspring would be homozygous, the
finding of 18% with Doppler abnormalities would suggest
that only three-quarters of the E16.5 homozygous offspring
exhibit outflow tract obstruction. It should be noted that
extensive breeding of these transgenic mice has consis-
tently shown normal Mendelian segregation of the trans-
gene.
Histological Analysis of the Heart Malformation
Histological analysis of FC and FE fetal hearts showed
various abnormalities in the right ventricle and pulmonary
outflow tract, but no abnormalities were detected in the left
ventricle. Most surprising was the finding of cartilage
nodules at the base of the semilunar valves in two E17.5 FC
hearts (Figs. 6A and 6B). Although cartilage can be found in
the hearts of older animals, the presence of cartilage is not
a normal feature in fetal mouse hearts (S. Viragh, personal
communication). Interestingly, smooth muscle actin ex-
pression in the myocardium was upregulated in the region
surrounding the cartilage nodules (Fig. 6B and data not
shown). Upregulation of smooth muscle actin was also
observed in the myocardium surrounding the pouches in
the outflow tract of a1 connexin knockout mouse hearts
(not shown; Huang et al., 1998). In line FE, hyperptrophy of
the right ventricular and interventricular myocardium was
occasionally observed (Figs. 6C–6E), and in some cases this
resulted in a near complete occlusion of the right ventric-
ular subpulmonary outflow tract (Fig. 6D). In some of the
FC fetal hearts, the myocardium of the anterosuperior
portion of the right ventricle appeared coarsely trabeculated
(not shown). Abnormal myocardial “bulging” of the ven-
FIG. 5. Abnormal heart function detected by in utero Doppler
echocardiography. (A) Cardiac blood flow seen by Doppler echocar-
diography in a normal E16.5 nontransgenic embryo. Peak systolic
ejection velocity in this embryo is 0.28 m/s (see white arrow). A, A
wave; E, E wave; inflow, inflow waveform; outflow, outflow wave
form; ICT, isovolemic contraction time. (B) An E16.5 FE transgenic
mouse embryo exhibited a peak systolic ejection velocity of 0.42
m/s (see white arrow), considerably higher than that in control
nontransgenic embryos (see A).
TABLE 2
Dye Coupling in FC Transgenic and Cx43 Knockout Embryos*
Mouse strain No. dye-filled cells
FC
Hemizygous 3.25 6 1.3 (65)
Nontransgenic 4.25 6 1.08 (28)
P , 0.0001*
a1 connexin knockout
2/2 2.44 6 0.73 (16)
2/1 3.63 6 1.00 (48)
1/1 4.75 6 0.94 (24)
P , 0.0001**
*P value derived from Student’s t test.
**P value based on ANOVA.
TABLE 3
Analysis of Cardiac Function by in Utero
Doppler Echocardiography
Mouse strain Fetal age No. fetuses IPSVa
FC D12.5 4 1
D16.5 9 2




a Number of embryos showing increased peak systolic ejection
velocity of 39.6 6 3.6 m/s vs 22.9 6 5.4 (P value , 0.0001).
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tricular walls was also occasionally observed (Figs. 6D and
6E).
DISCUSSION
Transgenic mice were generated expressing an a1
connexin/b-galactosidase fusion protein under the regu-
lation of the human elongation factor-1a promoter. Very
few viable transgenic founders were obtained, suggesting
that expression of this fusion protein is deleterious. This
is not likely due to an intrinsic cell lethality, since tissue
culture cells transfected with the same expression vector
can exhibit high levels of fusion protein expression
(Sullivan and Lo, 1995). In the viable transgenic lines,
only low levels of transcript and fusion protein expres-
sion were observed, but nevertheless there was a signifi-
cant reduction in gap junctional communication. These
results indicate that this fusion protein can be highly
effective in exerting dominant negative effects on gap
junctional communication. The fact that coupling was
not completely ablated by the fusion protein may indi-
cate either an insufficient level of fusion protein expres-
sion or that the fusion protein is unable to interact with
other connexin isotypes that are expressed.
Transgene expression was found to be restricted predomi-
FIG. 6. Histological analysis of E17.5 FC and FE hearts. (A, B) Sections of the hearts of transgenic littermates from the FC line. The section
shown in A is stained using hematoxylin–eosin, whereas the section shown in B was immunohistochemically labeled for smooth muscle
actin. In both hearts, a cartilage nodule was observed at the base of the semilunar valves of the pulmonary trunk (arrows). Note the high
level of smooth muscle actin expression in the surrounding myocardium in B. (C–E) Hematoxylin–eosin-stained sections of two FE hearts
(D and E are sections from the same heart). The right ventricular myocardium was severely hypertrophied, resulting in the obstruction of
the right ventricular inflow region (C and E) and the subpulmonary ventricular outflow tract (D). Some hearts also showed abnormal
“bulging” of the ventricular myocardium (asterisk in D and area between arrows in E). The image in E also shows abnormal morphology
in the atrioventricular region—note the abnormal tricuspid valve leaflet attachment (asterisk). It is important to note that the left ventricle
is not affected in these hearts. Ao, aorta; AVS, atrioventricular sulcus; LA, left atrium; LV, left ventricle; Pu, pulmonary trunk; RA, right
atrium; RV, right ventricle; RVOFT, right ventricular outflow tract.
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nantly to the neural tube, subpopulations of neural crest
cells, and various structures derived from neural crest cells.
As this same embryonic expression pattern was detected in
three independent transgenic lines, it likely represents
expression mediated by the elongation factor-1a promoter
construct. This result, however, differs markedly from the
previous report of widespread lacZ reporter gene expression
driven by the same promoter (Hanaoka et al., 1991; Kim et
al., 1990). Given the potential for viability problems arising
from expression of the fusion protein, a likely explanation
is that the restricted expression pattern was selected based
on its compatibility with postnatal survival and may reflect
expression specified by a subset of regulatory element(s) in
the promoter sequence.
All three transgenic lines expressing the fusion protein
were found to be homozygote inviable, with presumptive
homozygote animals dying at birth and exhibiting heart
defects. Of particular significance is the fact that the heart
malformation is localized to the RVOFT, the same region
affected in the a1 connexin knockout mice. Also similar to
the knockout mice is the finding of outflow tract obstruc-
tion in the FZ transgenic mice. In addition, we observed an
abnormal persistence of smooth muscle a-actin expression
in the conotruncal myocardium of the FC transgenic heart,
an abnormality also seen in the conotruncal pouches of the
a1 connexin knockout mouse heart (Huang et al., 1998).
The similarities in cardiac phenotype would suggest that
the loss of function mediated by the fusion protein mimics
the recessive loss of a1 connexin function in the knockout
mice. However, we note that the heart phenotypes in these
two mouse models, though similar, are not identical. This
could be due to differences in the expression pattern of the
fusion protein transgene compared to that of the endoge-
nous a1 connexin gene. For example, a1 connexins are
normally expressed in all neural crest cells (Lo et al., 1997),
but the transgene is only expressed in subpopulations of
neural crest cells. Another possibility is that the difference
stems from the fact that the fusion protein causes a reduc-
tion in the level of gap junctional communication in a
qualitatively different manner from that of the null mutant
mice.
Neural Crest Perturbation and Right Ventricular
Heart Malformation
The pattern of transgene expression would suggest that
crest perturbation is pivotal to the heart defects in the FZ
transgenic mice. This possibility is supported by the fact
that gap junctional communication in cardiac crest cells is
significantly reduced in these transgenic mice. A role for
crest perturbation has also been proposed for the heart
defects in the a1 connexin knockout mice. This was based
on the fact that restoration of a1 connexin function to
cardiac crest cells via the CMV43 transgene can ameliorate
the knockout heart phenotype (Ewart et al., 1997). Together
these observations suggest that a reduction of gap junc-
tional communication in cardiac crest cells, whether from
the dominant negative inhibition of gap junctional commu-
nication or the recessive loss of connexin function, is
detrimental to RVOFT development.
It should be noted that RVOFT heart malformation arises
not only from the loss of a1 connexin function, as it is also
exhibited by the CMV43 transgenic mice in which coupling
in crest cells is elevated due to a1 connexin overexpression.
Thus, it is likely that critical to outflow tract morphogen-
esis is not merely whether a1 connexin function is present
or absent, but rather the quantitative modulation of gap
junctional communication in cardiac crest cells. Our recent
finding that the heterozygous a1 connexin knockout mouse
also exhibits RVOFT defect, but of reduced severity, is
consistent with this notion (Huang et al., 1998). As might
be expected, dye-coupling analysis showed that gap junc-
tional communication in cardiac crest cells of the heterozy-
gous knockout mouse is intermediate to that of the wild-
type and homozygous knockout mice.
a1 Connexin Function and Cell–Cell Signaling
It is interesting to consider what might be the basis for
the quantitative requirement for a1 connexin function in
cardiac crest cells in light of the permeability properties of
gap junctions. We are currently investigating whether gap
junctional communication may mediate cell signaling in-
volved in the modulation of cardiac crest activity. With
regard to this possibility, it will be interesting to examine
the involvement of gap junctional communication in me-
diating cell signaling events linked to cytokines found
along the cardiac crest migratory pathway (Lo and Wessels,
1998). Gap junctional communication may help to propa-
gate extracellular signals received at the migration front to
other cells in a migratory stream and in this manner
facilitate the coordinate regulation of migration, prolifera-
tion, and/or differentiation of crest cells in response to
environmental cues. The up- or downregulation of gap
junctional communication may be expected to alter such
cell–cell signaling and thus lead to the perturbation of crest
activity. Our preliminary studies indicate that changes in
the level of gap junctional communication can alter the
migratory response of crest cells to cytokine stimulation
(Huang and Lo, unpublished observations). Also of interest
to note is our finding of abnormal smooth muscle a-actin
expression in the conotruncal myocardium in the FC trans-
genic and a1 connexin knockout mice. This would suggest
that gap junction perturbation in cardiac crest cells also
may have effects on the differentiation of the myocardium.
Whether this is mediated via a paracrine pathway or
through coupling between crest cells and the myocardium
remains to be determined.
Perturbation of Connexin Function and the Crest
Ablation Heart Phenotype
Although our studies strongly suggest the involvement of
crest perturbation in the RVOFT defects arising with the
gain or loss of a1 connexin function, it is significant that
the heart phenotypes exhibited by the FZ, CMV43, and
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connexin knockout mice differ markedly from the classic
cardiac crest ablation phenotype (Kirby et al., 1983, 1985;
Bockman et al., 1987; Nishibatake et al., 1987). With
cardiac crest ablation, typically outflow septation anoma-
lies are observed, but this is never seen with the loss or gain
of a1 connexin function. This would suggest that a1 con-
nexins are not involved in the maintenance of crest cell
viability. Instead, it may be the migration, proliferation,
and/or differentiation of crest cells that is being modulated
by a1 connexin-mediated gap junctional communication.
With regard to these possibilities, it is interesting to con-
sider the finding of cartilage nodules in the heart of FC
transgenic mice. It has been shown that cranial crest cells
when transplanted to ectopic sites can give rise to cartilage
(LeDourain and Teillet, 1974; Kirby, 1989). Thus, inhibition
of coupling in neural crest cells by the fusion protein could
have resulted in the inappropriate migration of noncardiac
crest cells to the heart. Alternatively, it may be that the
cartilage nodules are derived from cardiac crest cells that
have differentiated inappropriately. Given these observa-
tions, it is interesting to consider whether clinically there
may be heart anomalies involving crest perturbation that
has not been recognized as such. One example might be
heart anomalies described as pulmonary stenosis with in-
tact ventricular septum (McQuinn, 1996).
Although our studies have focused on heart malforma-
tions associated with the perturbation of gap junctional
communication in cardiac crest cells, it is likely that other
crest lineages may be affected. Thus, we have observed
cranial ganglia defects in the FZ transgenic and a1 connexin
knockout mice, structures containing crest contributions
that are also affected in the CMV43 transgenic mice (Ewart
et al., 1997; Lo and Sullivan, unpublished observations).
Also possibly of relevance is our finding of cranial neural
tube closure defects in both the FZ transgenic and a1
connexin knockout mice (Sullivan and Lo, unpublished
observations), a phenotype shared by the CMV43 transgenic
mice (Ewart et al., 1997). Studies by others suggest that
neural tube closure defects could arise in conjunction with
or secondarily from defects in the deployment of neural
crest cells (Morriss-Kay et al., 1994; also see Moase and
Trasler, 1989, 1990; Nieto et al., 1994; Chen et al., 1995).
Dominant Negative Approach for Modulating
Connexin Function
Our studies show the efficacy of a dominant negative
approach for manipulating gap junctional communication
in transgenic mice. It should be noted that previously a
hybrid mammalian connexin protein was observed to in-
hibit gap junctional communication in a dominant negative
manner in Xenopus embryos, and its expression disrupted
early events in Xenopus development (Paul et al., 1995).
Our studies represent the first example in which a domi-
nant negative approach has been successfully used in mam-
malian embryos.
A dominant negative approach is a powerful tool for the
analysis of gene function, as it provides the means for
examining the effects of functional perturbation targeted to
a restricted cell lineage or tissue. This may be particularly
important for the analysis of genes that are widely ex-
pressed, such as the a1 connexin gene (Ruangvoravat and
Lo, 1992). Thus, our study here provided evidence of neural
crest perturbation as the basis for the heart malformations
seen with the loss of a1 connexin function. A dominant
negative approach also may be advantageous as the use of a
suitable promoter to target expression may obviate the
neonatal knockout lethality and allow a1 connexin func-
tion to be examined postnatally. It may also be possible to
inhibit the function of multiple connexin isotypes simulta-
neously, thereby overcoming some of the functional redun-
dancies inherent in a multigene family. However, whether
the a1 connexin/lacZ fusion protein can interact with
multiple connexin isotypes is not yet known, but hetero-
meric connexins are known to exist (Staufer, 1995).
In future studies, the role of gap junctions in mammalian
development can be further explored by targeting expres-
sion of the a1 connexin/b-galactosidase fusion protein
using different promoter constructs. By targeting tissues
other than the cardiac neural crest, it may be possible to
achieve long-term postnatal viability and thus allow the
examination of a1 connexin function in other cells and
tissues. The presence of the b-galactosidase reporter will
allow the tracking of fusion protein expression, either on a
cellular level by the histochemical localization of
b-galactosidase activity or on a quantitative level by the
biochemical determination of b-galactosidase enzymatic
activity.
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